Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
DDX58 Antibody, RIG-1 Antibody, RIG-I Antibody, RLR-1 Antibody, Retinoic acid inducible gene I Antibody, RIG-I-like receptor 1 Antibody, RIGI Antibody, DEAD box protein 58 Antibody, RNA helicase RIG-I Antibody
Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and proinflammatory cytokines. Its ligands include: 5'-triphosphorylated ssRNA and dsRNA and short dsRNA (<1 kb in length). In addition to the 5'-triphosphate moiety, blunt-end base pairing at the 5'-end of the RNA is very essential.
IHC of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-DDX58 mouse monoclonal antibody.
IHC of paraffin-embedded Human pancreas tissue using anti-DDX58 mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-DDX58 mouse monoclonal antibody.
IHC of paraffin-embedded Human Kidney tissue using anti-DDX58 mouse monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DDX58 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DDX58.
Requested From: United States
Date Requested: 1/22/2017